Viewing Study NCT05400603


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-04 @ 3:32 PM
Study NCT ID: NCT05400603
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2022-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module